6 Alzheimers Disease Clinical Trials in Encino, CA (2026)

Q: How do I join a clinical trial in Encino?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Encino research site will contact you.

Recruiting Alzheimers Disease Studies in Encino

NCT05889182Recruiting

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how s...

Encino, CAPHASE31,328 participantsAbbVie

View Study Details

NCT05980949Recruiting

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT and KarXT + KarX-EC in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027, CN012-0056 or CN012-0034. Subjects (randomized or non-ra...

Encino, CAPHASE31,000 participantsKaruna Therapeutics

View Study Details

NCT06126224Recruiting

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female subjects who are aged 55 to 90 years and have mild...

Encino, CAPHASE3500 participantsKaruna Therapeutics, Inc., a Bristol Myers Squibb company

View Study Details

NCT05511363Recruiting

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Alzheimer's Disease. The primary objective of the st...

Encino, CAPHASE3410 participantsKaruna Therapeutics

View Study Details

NCT05397639Recruiting

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the...

Encino, CAPHASE3375 participantsSuven Life Sciences Limited

View Study Details

NCT04879329Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It will also test how safe the drug is for participan...

Encino, CAPHASE2372 participantsSeagen, a wholly owned subsidiary of Pfizer

View Study Details

About Alzheimers Disease Clinical Trials in Encino

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 6 alzheimers disease clinical trials recruiting participants in Encino, CA. These studies are seeking a combined 3,985 participants. Research is being sponsored by AbbVie, Karuna Therapeutics, Karuna Therapeutics, Inc., a Bristol Myers Squibb company and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Encino — FAQ

Are there alzheimers disease clinical trials in Encino?

Yes, there are 6 alzheimers disease clinical trials currently recruiting in Encino, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Encino?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Encino research site will contact you about next steps.

Are clinical trials in Encino free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Encino studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 6 active trials in Encino are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 20, 2026 from ClinicalTrials.gov